Free Trial

CME Group (CME) Stock Forecast & Price Target

$196.17
+0.67 (+0.34%)
(As of 11:57 AM ET)

CME Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$215.90
10.06% Upside
High Forecast$245.00
Average Forecast$215.90
Low Forecast$187.00
TypeCurrent Forecast
7/3/23 to 7/2/24
1 Month Ago
6/3/23 to 6/2/24
3 Months Ago
4/4/23 to 4/3/24
1 Year Ago
7/3/22 to 7/3/23
Consensus Rating
Reduce
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
7 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
3 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$215.90$217.80$218.36$210.91
Forecasted Upside10.06% Upside1.93% Upside3.71% Upside14.76% Upside

CME Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CME Group Stock vs. The Competition

TypeCME GroupFinance CompaniesS&P 500
Consensus Rating Score
1.90
2.44
2.50
Consensus RatingReduceHoldModerate Buy
Predicted Upside10.43% Upside63.47% Upside12.45% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$206.00 ➝ $187.00-5.79%
4/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$226.00 ➝ $228.00+6.86%
4/25/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$209.00 ➝ $216.00+1.28%
4/25/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$222.00 ➝ $226.00+4.71%
4/25/2024Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSell ➝ Sell$185.00 ➝ $187.00-12.04%
4/9/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$222.00 ➝ $225.00+6.53%
[Breakthrough] The "Drug Smuggler" Curing Brain Disease? (Ad)

This small, under-the-radar firm has cracked the code with its proprietary "Drug Smuggler" platform. This revolutionary delivery technology could unlock a universe of new therapies for Alzheimer's, Parkinson's and other neurodegenerative diseases.

Don't miss out - get the full story on this game-changing biotech play >>>
4/5/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$235.00 ➝ $210.00-1.26%
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$225.00 ➝ $245.00+12.27%
1/3/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$195.00-6.80%
10/12/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$215.00 ➝ $240.00+10.55%
4/12/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$213.00 ➝ $221.00+15.26%
2/7/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$192.00 ➝ $198.00+13.30%
1/5/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$226.00 ➝ $220.00+29.35%
12/19/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$270.00 ➝ $250.00+46.10%
8/15/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:15 PM ET.

CME Forecast - Frequently Asked Questions

What is CME Group's stock forecast and purchase recommendation?

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $215.90, with a high forecast of $245.00 and a low forecast of $187.00. The consensus rating for CME Group stock is Reduce based on the current 3 sell ratings, 5 hold ratings and 2 buy ratings for CME. Learn more on CME's analyst rating history.

Do Wall Street analysts like CME Group more than its competitors?

Analysts like CME Group less than other "finance" companies. The consensus rating for CME Group is Reduce while the average consensus rating for "finance" companies is Hold. Learn more on how CME compares to other companies.

Is CME Group being downgraded by Wall Street analysts?

Over the previous 90 days, CME Group's stock had 1 downgrade by analysts.

Does CME Group's stock price have much upside?

According to analysts, CME Group's stock has a predicted upside of 1.74% based on their 12-month stock forecasts.

What analysts cover CME Group?

This page (NASDAQ:CME) was last updated on 7/2/2024 by MarketBeat.com Staff

From Our Partners